Evaluation of Age-Specific Efficacy and Safety of 12 Months of Sitagliptin Therapy Administered by Non-Diabetologists

Journal of Endocrinology and Metabolism - Canada
doi 10.14740/jem634
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Efficacy of Propranolol Between 6 and 12 Months of Age in High-Risk Infantile Hemangioma

Pediatrics
Child HealthPediatricsPerinatology
2018English

Efficacy and Safety of Non-Pegylated Liposomal Doxorubicin in Metastatic Breast Cancer Therapy

OnCOReview
Oncology
2017English

Efficacy and Safety of Inhaled Insulin Therapy

Annals of Internal Medicine
Internal MedicineMedicine
2006English

Figure 2: Nomogram for Predicting 6 Months, 12 Months, 18 Months and 24 Months Cancer-Specific Death of VEOPC Patients.

English

Efficacy and Safety of 12 Versus 48 Months of Dual Antiplatelet Therapy After Implantation of a Drug-Eluting Stent: The OPTImal DUAL Antiplatelet Therapy (OPTIDUAL) Trial: Study Protocol for a Randomized Controlled Trial

Trials
MedicinePharmacology
2013English

Infants' Visual Recognition of Pincer Grip Emerges Between 9 and 12 Months of Age

Infancy
Child HealthDevelopmentalPediatricsPerinatologyEducational Psychology
2016English

Efficacy of Cilofungin Therapy Administered by Continuous Intravenous Infusion for Experimental Disseminated Candidiasis in Rabbits.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1992English

Efficacy of Baby-Cimt: Study Protocol for a Randomised Controlled Trial on Infants Below Age 12 Months, With Clinical Signs of Unilateral CP

BMC Pediatrics
Child HealthPediatricsPerinatology
2014English

Pancreatic Safety of Sitagliptin in the TECOS Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy